Increasing Cases of Kidney Diseases among Millennials Expected to Augment the Growth of the Global Nephrology Drugs Market by 2028 [170-Pages] | Report by Research Dive
23 mars 2022 09h15 HE
|
Research Dive
New York, USA, March 23, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global nephrology drugs market is estimated to garner $21,454.5 million in revenue and rise...
Recro Announces Name Change to Societal CDMO to Reflect Corporate Expansion and Transformation
21 mars 2022 07h00 HE
|
Recro Pharma, Inc.
With Expanded Industry Expertise, Enhanced Service Offerings and Bi-Coastal Operations, Company Now Optimally Positioned to Support Customers’ Goal of Delivering Impactful Medicines to SocietyNew...
Catalyst Pharmaceuticals and KYE Pharmaceuticals Announce a Second Favorable Canadian Federal Court Ruling Setting Aside Approval of Ruzurgi®
11 mars 2022 08h03 HE
|
Catalyst Pharmaceuticals, Inc.
CORAL GABLES, Fla., March 11, 2022 (GLOBE NEWSWIRE) -- Catalyst Pharmaceuticals, Inc. ("Catalyst") (Nasdaq: CPRX), a commercial-stage, patient-centric biopharmaceutical company focused on...
Recro to Present at H.C. Wainwright BioConnect 2022 Conference
03 janv. 2022 07h00 HE
|
Recro Pharma, Inc.
SAN DIEGO and GAINESVILLE, Ga., Jan. 03, 2022 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex...
Avid Bioservices to Report Financial Results for Second Quarter of Fiscal Year 2022 After Market Close on December 7, 2021
30 nov. 2021 16h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 30, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Avid Bioservices Appoints Elie G. Hanania, Ph.D., as Vice President, Process Development, Viral Vector Technologies
04 nov. 2021 08h05 HE
|
Avid Bioservices, Inc
TUSTIN, Calif., Nov. 04, 2021 (GLOBE NEWSWIRE) -- Avid Bioservices, Inc. (NASDAQ:CDMO), a dedicated biologics contract development and manufacturing organization (CDMO) working to improve patient...
Anatomic Pathology Market Size ($33,145.78Mn by 2028) Lead by Services Segment (40.04% Revenue Share in 2021) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
02 nov. 2021 13h23 HE
|
The Insight Partners
New York, Nov. 02, 2021 (GLOBE NEWSWIRE) -- Anatomic Pathology Market: Key Insights According to our new research study on Anatomic Pathology Market Size and Forecast to 2028 - COVID-19 Impact and...
Clearmind Medicine Files Provisional Patent Application Related to Methods of Drug-Assisted Psychotherapy
13 oct. 2021 08h00 HE
|
Clearmind Medicine
TORONTO, Ontario, Oct. 13, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Clearmind Medicine Inc. (CSE: CMND) (FSE: CWY0) (“Clearmind” or the "Company"), a psychedelic medicine biotech company focused...
vTv Therapeutics Announces Results of Multiple Ascending Dose Study and Development Plan for HPP737, an Oral PDE4 Inhibitor for the Treatment of Psoriasis
23 sept. 2021 16h30 HE
|
vTv Therapeutics Inc.
HPP737 exhibited favorable safety and tolerability profile, with no dose limiting gastrointestinal side effects Results build on data from previous multiple ascending dose study and support...
Recro Signs Renewable Energy Agreement With Georgia Power
21 sept. 2021 07h00 HE
|
Recro Pharma, Inc.
EXTON, Pa., Sept. 21, 2021 (GLOBE NEWSWIRE) -- Recro Pharma, Inc. (“Recro”; NASD: REPH), a contract development and manufacturing organization (CDMO) dedicated to solving complex formulation and...